- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04239924
Community Paramedic Coaching Program for Caregivers and People With Dementia (CP3D)
Community Paramedic Coaching Program for Caregivers and People With Dementia (CP3D)
Study Overview
Detailed Description
The intervention is an adaptation of the evidence-based REACH program (Resources Enhancing Alzheimer's Caregiver Health), designed for and validated in multiple settings to give education, tools, and support to informal caregivers of people with dementia, delivered through a series of at-home visits (minimum of 9 in-person and 3 phone sessions) conducted by trained and certified coaches over 6-12 months. The content of the coaching visits will follow the REACH program protocol, with materials customized with information about local community resources (e.g., Dane County).
Coach/administrator training for delivery of the REACH intervention will be conducted by master trainers from the Rosalynn Carter Institute (RCI) for Caregiving, a department of Georgia Southwestern State University, who administers, certifies, and provides oversight for REACH sites nationally (https://www.rosalynncarter.org/programs/rci-reach/). For the purposes of this pilot study, the investigators have coordinated with RCI to extend delivery of REACH content over a 12-month period, with home visits occurring more frequently at the beginning and spreading further apart towards the end, and additional phone "REVIEW" sessions between home-visits.
Each home visit covers specific coaching content, building on strategies and behaviors covered in prior sessions. The program includes flexibility to allow coaches to adapt the timing/delivery of content to attend to the needs of the caregiver (e.g., answering questions about previously-covered topics, covering topics from a future visit to help coach a caregiver through an emergent dementia-related issue). Sessions typically last 1-2 hours. Following each visit, the coach completes a fidelity checklist and writes client progress notes as per the REACH protocol.
This pilot adapts prior REACH implementations in two main ways: (1) intervention coaches will be community paramedics with advanced medical training, rather than social workers (or other non-medical social service personnel), and (2) the program will be formally coordinated with the participant and caregiver's primary care practice, allowing for care coordination and information sharing between participants, coaches, and clinic staff/providers. Participants will also have the ability to share information about their use of community dementia care resources (e.g., social services, transportation, senior center case management, dementia caregiver support groups, dementia-related educational programming, respite) with coaches so they can communicate necessary information to the clinic for possible inclusion in the participant's Electronic Health Record (EHR) (as per the clinic's determination), facilitate care coordination, and help keep the participant's care plan up to date. Paramedic coaches will be utilizing their medical knowledge, but not providing any direct medical care.
This pilot study also differs from prior REACH trials in that outcome measures include health care and emergency services utilization, particularly related to the occurrence of acute medical and behavioral problems, as well as perceptions of health care quality, in addition to caregiver psycho-socio-emotional measures (already included in the standard REACH assessment package).
The study will employ a stepped design using a rapid-cycle evaluation approach. Three cohorts of 4-5 patient-caregiver dyads each will start the intervention at staggered intervals. Within each cohort, a new dyad will begin the program approximately every two weeks, with an approximate four week gap between each cohort for feedback collection and program iteration. Real-time feedback obtained from multiple intervention stakeholders (caregivers, persons with dementia, coaches, clinical staff/providers - up to 10 enrolled) will be used to iteratively improve intervention delivery and program implementation for the next, all while the first group continues the pilot. In this way, problems can be identified and solutions generated, with enough time to adapt the program and evaluate revisions. Staggering participant start dates allows for multiple rapid-cycle iterations within a single pilot study.
NOTE: While COVID-19 restrictions are in place, all feedback interviews will take place by telephone or WebEx videoconferencing, beginning 17 March 2020.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53705
- University of Wisconsin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Patient Inclusion Criteria:
- Diagnosis or indication in medical record of mild to moderate dementia (any subtype)
- English speaking
- Community-dwelling (independent and assisted living acceptable)
- Living with their primary informal caregiver
- Patient of a UW Health primary care provider affiliated with and participating in the study
Patient Exclusion Criteria:
- Receiving intensive care management services
- Receiving aggressive care for another condition (e.g., chemotherapy for cancer, surgery planned for problem)
- In isolation due to contagious illness
- Enrolled in home hospice
- Currently incarcerated, in police custody, or ward of the state
- Legally blind or deaf (unable to hear or see even with assistive devices)
- Lacks decisional capacity and no available legally authorized representative (LAR) to provide consent
- Patient refuses enrollment
Caregiver Inclusion Criteria:
- Adult informal caregiver (≥18 years old) of a person eligible for this study (determination based upon caregiver self-identification).
- Lives in the same household (primary residence) as the patient with dementia.
- Has a working telephone
- English speaking
- UW Health primary care provider
Caregiver Exclusion Criteria:
- Unable to participate in the program as defined
- Employed by a professional/private agency to provide care to the care recipient (i.e., professional caregiver, not an informal caregiver)
- Has a diagnosis of dementia or cognitive impairment causing functional impairment
- In isolation due to contagious illness
- Legally blind or deaf (unable to hear or see even with assistive devices)
- Refuses enrollment
Stakeholder Inclusion Criteria:
- Involved in the implementation study activities in related to the intervention, either as a clinician, member of the UW Health staff, paramedic coach, or social service provider.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Paramedic Coaching
The intervention is an adaptation of the evidence-based REACH program
|
The intervention is an adaptation of the evidence-based REACH program, specific coaching content is delivered by paramedics in 1-2 hour in-home sessions and over the phone throughout a 12-month period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility: Proportion of Coaching Phone Calls Completed
Time Frame: up to 12 months
|
The intervention will be deemed feasible if at least 75% of the intended coaching phone calls are completed.
The minimum number of coaching calls is 3, additional calls will be scheduled opposite weeks of home visits as needed.
|
up to 12 months
|
Feasibility: Proportion of Coaching Home Visits Completed
Time Frame: up to 12 months
|
The intervention will be deemed feasible if at least 75% of the intended home visits are completed.
The minimum number of intended home visits is 9.
|
up to 12 months
|
Number of Visits to the Emergency Department by the Person With Dementia
Time Frame: up to 24 months
|
As determined by abstracting the medical records, the investigators are testing the hypothesis that the number of visits to the Emergency Department is lower than commonly reported in the literature for persons with dementia.
|
up to 24 months
|
Number of Visits to the Emergency Department by the Caregiver of the Person With Dementia
Time Frame: up to 24 months
|
As determined by abstracting the medical records, the investigators are testing the hypothesis that the number of visits to the Emergency Department is lower than commonly reported in the literature for average older adults.
|
up to 24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Zarit Burden Interview (ZBI-12) Score
Time Frame: First home visit (~ week 1), week 13, week 25, and last home visit (~up to week 50)
|
The Zarit Burden Interview measures caregiver burden.
This is a 12-item survey with a total possible range of scores from 0-48, where higher scores indicate increased burden.
The investigators hypothesize the score will decrease as a result of the intervention.
|
First home visit (~ week 1), week 13, week 25, and last home visit (~up to week 50)
|
Change in Generalized Anxiety Disorder (GAD-7) Score
Time Frame: Baseline, week 13, week 25, week 50
|
The GAD-7 is a 7-item survey that measures anxiety symptom severity.
The total possible range of scores is 0-21, where higher scores indicate increased symptom severity.
The investigators hypothesize the score will decrease as a result of the intervention.
|
Baseline, week 13, week 25, week 50
|
Change in Center for Epidemiologic Studies Depression Scale (CESD-10)
Time Frame: First home visit (~ week 1), week 13, week 25, and last home visit (~up to week 50)
|
The CESD-10 is a general measure of depression frequently used in caregiver studies.
It is a 10-item survey with a total possible range of scores of 0-30 where higher scores indicate increased depression.
The investigators hypothesize the score will decrease as a result of the intervention.
|
First home visit (~ week 1), week 13, week 25, and last home visit (~up to week 50)
|
Change in Revised Caregiving Satisfaction Scale (RCSS)
Time Frame: Baseline, week 13, week 25, week 50
|
The RCSS is a 6-item survey used to measure the positive aspects of caring.
The range of total possible scores is 6-30 where higher scores indicate increased caregiver satisfaction.
The investigators hypothesize the score will increase as a result of the intervention.
|
Baseline, week 13, week 25, week 50
|
Change in Revised Scale for Caregiving Self-Efficacy
Time Frame: First home visit (~ week 1) and last home visit (~up to week 50)
|
The revised scale for caregiving self-efficacy measures three domains: obtaining respite, responding to disruptive patient behaviors, and controlling upsetting thoughts.
It is a 15-item scale with a total possible range of scores between 0-100, where higher scores are better.
The investigators hypothesize the score will increase as a result of the intervention.
|
First home visit (~ week 1) and last home visit (~up to week 50)
|
Change in Work-Family Conflict Scale (WFC)
Time Frame: First home visit (~ week 1) and last home visit (~up to week 50)
|
WFC is measured for the caregiver.
It is a 6-item survey with a total possible range of scores between 6-30 with higher scores indicating lesser work-family conflict.
The investigators hypothesize the score will increase as a result of the intervention.
|
First home visit (~ week 1) and last home visit (~up to week 50)
|
Change in Caregiver Quality of Life (C-DEMQOL) Score
Time Frame: First home visit (~ week 1), week 13, week 25, and last home visit (~up to week 50)
|
C-DEMQOL is measured for the caregiver.
The investigators will be asking 18 of the questions from the scale to understand the quality of life the caregivers experience.
Scores can range from 18-90, with a higher score reflecting a higher quality of life.
|
First home visit (~ week 1), week 13, week 25, and last home visit (~up to week 50)
|
Change in Knowledge of Dementia (DKAS) Score
Time Frame: First home visit (~ week 1) and week 13
|
DKAS is measured for the caregiver.
It is a 25 item true-false survey of facts about dementia.
Scoring is by measuring the proportion of questions answered correctly.
The range for score values is 0 to 50, the higher the score the better the outcome (a.k.a. the more knowledgeable about dementia).
|
First home visit (~ week 1) and week 13
|
Clinic Utilization by Persons With Dementia
Time Frame: up to 24 months
|
As determined by abstracting the medical records, the investigators are characterizing the number of contacts with outpatient clinics for persons with dementia.
|
up to 24 months
|
Clinic Utilization by Caregivers of Persons With Dementia
Time Frame: up to 24 months
|
As determined by abstracting the medical records, the investigators are characterizing the number of contacts with outpatient clinics for caregivers of persons with dementia.
|
up to 24 months
|
Change in Caregiver Perceptions About Communication With Clinical Team Members (CAPACITY) Measure
Time Frame: First home visit (~ week 1) and week 13
|
Assesses caregivers perception of communication with health care team and extent to which the team considers their capacity and preferences in decision making.
This measure consists of 12 questions, with scores ranging from 12-60, where higher scores indicate increased communication with the health care team.
|
First home visit (~ week 1) and week 13
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Manish N Shah, MD, MPH, University of Wisconsin, Madison
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-1218
- A534100 (Other Identifier: UW Madison)
- SMPH/EMERG MED (Other Identifier: UW Madison)
- K24AG054560 (U.S. NIH Grant/Contract)
- Protocol Version 1/20/2021 (Other Identifier: UW Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityRecruitingDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeRecruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Cognito Therapeutics, Inc.Enrolling by invitationExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)Cognitive Impairment | Alzheimer Disease | Mild Cognitive Impairment | Dementia Alzheimers | Dementia of Alzheimer Type | AD | Dementia, Mild | Dementia ModerateUnited States
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
-
University College, LondonNot yet recruitingDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal | DEM
-
University College, LondonThe University of Hong KongUnknownDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal
-
Karolinska InstitutetRegion Stockholm; KTH Royal Institute of TechnologyActive, not recruitingAlzheimer Dementia | Dementia DisordersSweden
Clinical Trials on Paramedic Coaching
-
Centre Francois BaclesseRoche Pharma AGCompletedCancer | IV Anticancer TherapyFrance
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)SuspendedHypoglycemia | Diabetes | Diabetes Type 1 | Diabetes Type 2United States
-
Westfälische Wilhelms-Universität MünsterNational Paralympic Committee Germany (NPCG)CompletedCardiac Rehabilitation | Feasibility Studies | Organization and Administration | Rehabilitation ExerciseGermany
-
Barts & The London NHS TrustLondon Ambulance Service NHS TrustUnknownSupraventricular TachycardiaUnited Kingdom
-
Mayo ClinicCompletedStress | Anxiety | Leadership | Professional Role | Goals | Well-Being | Physician's Role | Professional Burnout | Development, HumanUnited States
-
Rigshospitalet, DenmarkGilead SciencesCompleted
-
Queen Mary University of LondonBarts & The London NHS TrustCompletedCardiovascular DiseaseUnited Kingdom
-
VA Office of Research and DevelopmentAtlanta VA Medical Center; Palo Alto VA Medical CenterRecruitingCardiovascular DiseasesUnited States
-
Creighton UniversityDexCom, Inc.Completed
-
NYU Langone HealthNational Institute on Aging (NIA)Not yet recruitingAlzheimer Disease | Alzheimer's Disease Related DementiaUnited States